Replimune (REPL) Accumulated Expenses (2018 - 2025)

Replimune has disclosed Accumulated Expenses across 8 years of filings, most recently posting $40.4 million for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $40.4 million, up 9.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $40.4 million (up 9.81% YoY), and the FY2025 annual result was $45.9 million, up 35.12% from the prior year.
• Accumulated Expenses came in at $40.4 million for Q4 2025 at Replimune, down from $42.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $45.9 million in Q1 2025 to a low of $8.7 million in Q1 2021.
• The 5-year median for Accumulated Expenses is $27.8 million (2023), against an average of $25.6 million.
• Across the five-year window, Accumulated Expenses soared 441.52% in 2021 and fell 0.72% in 2024, its largest moves.
• Replimune's Accumulated Expenses stood at $10.8 million in 2021, then surged by 78.15% to $19.2 million in 2022, then soared by 61.22% to $30.9 million in 2023, then rose by 19.02% to $36.8 million in 2024, then advanced by 9.81% to $40.4 million in 2025.
• The last three Accumulated Expenses figures came in at $40.4 million (Q4 2025), $42.4 million (Q3 2025), and $40.0 million (Q2 2025), per Business Quant data.